CAPSTONE ASSET MANAGEMENT CO - SPECTRUM PHARMACEUTICALS INC ownership

SPECTRUM PHARMACEUTICALS INC's ticker is SPPI and the CUSIP is 84763A108. A total of 130 filers reported holding SPECTRUM PHARMACEUTICALS INC in Q1 2017. The put-call ratio across all filers is 0.44 and the average weighting 0.0%.

Quarter-by-quarter ownership
CAPSTONE ASSET MANAGEMENT CO ownership history of SPECTRUM PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2017$109,000
+9.0%
14,630
-4.5%
0.00%0.0%
Q1 2017$100,000
+29.9%
15,320
-11.3%
0.00%
+50.0%
Q4 2016$77,000
-3.8%
17,280
+0.6%
0.00%0.0%
Q3 2016$80,000
-29.8%
17,170
-1.1%
0.00%
-33.3%
Q2 2016$114,000
+3.6%
17,360
+0.1%
0.00%0.0%
Q1 2016$110,000
-2.7%
17,350
-7.7%
0.00%0.0%
Q4 2015$113,000
+0.9%
18,790
+0.4%
0.00%0.0%
Q3 2015$112,000
-5.1%
18,710
+8.2%
0.00%0.0%
Q2 2015$118,000
-22.9%
17,300
-31.3%
0.00%
-25.0%
Q1 2015$153,000
-11.0%
25,180
+1.2%
0.00%
-20.0%
Q4 2014$172,000
-27.1%
24,890
-14.2%
0.01%
-37.5%
Q3 2014$236,000
-1.7%
29,020
-1.5%
0.01%0.0%
Q2 2014$240,000
+9.6%
29,470
+5.3%
0.01%
+14.3%
Q1 2014$219,000
-13.1%
27,983
-1.7%
0.01%0.0%
Q4 2013$252,000
-19.0%
28,453
-23.3%
0.01%
-12.5%
Q3 2013$311,000
+14.8%
37,083
+2.2%
0.01%
+14.3%
Q2 2013$271,00036,2730.01%
Other shareholders
SPECTRUM PHARMACEUTICALS INC shareholders Q1 2017
NameSharesValueWeighting ↓
ALETHEA CAPITAL MANAGEMENT, LLC 1,177,115$1,495,0001.27%
ARMISTICE CAPITAL, LLC 9,665,756$12,276,0000.20%
CM Management, LLC 150,000$191,0000.14%
FSB PREMIER WEALTH MANAGEMENT, INC. 200,000$254,0000.11%
Manteio Capital LLC 57,586$73,0000.09%
GSA CAPITAL PARTNERS LLP 410,691$522,0000.07%
SYNTAX ADVISORS, LLC 29,181$37,0000.03%
CAXTON ASSOCIATES LP 164,096$208,0000.02%
Alpine Global Management, LLC 97,650$124,0000.02%
Sonora Investment Management Group, LLC 82,000$104,0000.01%
View complete list of SPECTRUM PHARMACEUTICALS INC shareholders